Tofacitinib ≥98%

Supplier: Van Der Voort Lucht en Milieu Amste
Danger

AG-CR1-3625-M005 AG-CR1-3625-M025
102988-814EA 83.08 USD
102988-814 102988-816
Tofacitinib ≥98%
Tofacitinib

Potent cell permeable JAK3 inhibitor (IC50 = 1nM). Shows also JAK-1 inhibitory activity. Immunosuppressive and anti-inflammatory agent. Inhibits signaling through heterodimeric receptors associated with JAK3, JAK1, or both of them, with functional selectivity over JAK2-paired receptors. Blocks downstream STAT signaling, resulting in potent inhibition of several cytokines, including interleukins 2, 4, 7, 9, 15 and 21, which are integral to lymphocyte activation, function and proliferation. Investigated for several autoimmune disorders including, rheumatoid arthritis and psoriasis. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro.

Formula: C₁₆H₂₀N₆O
MW: 312.4 g/mol
Storage Temperature: Freezer
MDL Number: MFCD11035919
CAS Number: 477600-75-2
UN: 2811
ADR: 6.1 III

Order Now

Specification Test Results

Purity 98%
Appearance/Color Off-white to pale yellow solid.
Solubility Soluble in DMSO or ethanol.


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR